These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 16298371)
1. Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population. Florez H; Mendez A; Casanova-Romero P; Larreal-Urdaneta C; Castillo-Florez S; Lee D; Goldberg R Atherosclerosis; 2006 Sep; 188(1):134-41. PubMed ID: 16298371 [TBL] [Abstract][Full Text] [Related]
2. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia. Maki KC; Bays HE; Dicklin MR; Johnson SL; Shabbout M J Clin Lipidol; 2011; 5(6):483-92. PubMed ID: 22108152 [TBL] [Abstract][Full Text] [Related]
3. [Gender differences and diabetic status in the relationship of blood apolipoprotein C-III, free fatty acids and triglycerides in subjects at risk for glucose intolerance]. Flórez H; Méndez AJ; Jones L; Goldberg RB Invest Clin; 1999 Mar; 40(1):51-66. PubMed ID: 10198561 [TBL] [Abstract][Full Text] [Related]
4. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size. Tani S; Matsumoto M; Nagao K; Hirayama A J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623 [TBL] [Abstract][Full Text] [Related]
5. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975 [TBL] [Abstract][Full Text] [Related]
6. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications? Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS. Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204 [TBL] [Abstract][Full Text] [Related]
8. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin. Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169 [TBL] [Abstract][Full Text] [Related]
9. Association between insulin resistance and apolipoprotein B in normoglycemic Koreans. Sung KC; Hwang ST Atherosclerosis; 2005 May; 180(1):161-9. PubMed ID: 15823289 [TBL] [Abstract][Full Text] [Related]
11. Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism with carotid intima-media thickness in Chinese type 2 diabetic patients. Chen X; Tian H; Liu R Diabetes Res Clin Pract; 2004 Oct; 66(1):41-7. PubMed ID: 15364160 [TBL] [Abstract][Full Text] [Related]
12. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes. Noto H; Chitkara P; Raskin P J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436 [TBL] [Abstract][Full Text] [Related]
13. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution. Tian L; Wu J; Fu M; Xu Y; Jia L Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590 [TBL] [Abstract][Full Text] [Related]
14. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients. Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267 [TBL] [Abstract][Full Text] [Related]
16. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851 [TBL] [Abstract][Full Text] [Related]
17. Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome. Söderlund S; Watanabe H; Ehnholm C; Jauhiainen M; Taskinen MR Metabolism; 2010 Oct; 59(10):1502-9. PubMed ID: 20206948 [TBL] [Abstract][Full Text] [Related]
18. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor? Chan DC; Chen MM; Ooi EM; Watts GF Int J Clin Pract; 2008 May; 62(5):799-809. PubMed ID: 18201179 [TBL] [Abstract][Full Text] [Related]
19. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445 [TBL] [Abstract][Full Text] [Related]